نتایج جستجو برای: post marketing surveillance
تعداد نتایج: 538652 فیلتر نتایج به سال:
Background: Recombinant activated factor VII induces hemostasis in patients with coagulopathy disorders. AryoSeven™ as a safe Iranian Recombinant activated factor VII has been available on our market. This study was performed to establish the safety of AryoSeven on patients with coagulopathy disorder. Methods: This single-center, descriptive,...
The presentation of the most recent developments in the field of drug safety falls very well within the scope of the Journal of Pharmacovigilance: pharmacogenetics is certainly one of these. It is the study of associations of genetic traits of individuals and their response to drugs and has become an important aspect to be considered both during drug development and in post-marketing surveillan...
Electronic Health Record (EHR) systems are becoming highly prevalent today and have the potential to add to the success of spontaneous reporting systems for post marketing surveillance of drugs. EHR systems broadly contain two forms of information viz. coded (structured) information and unstructured text. Researchers have shown that the textual data have much more utility for cohort building th...
The current state of the art in post-marketing drug surveillance utilizes voluntarily submitted reports of suspected adverse drug reactions. We present data mining methods that transform unstructured patient notes taken by doctors, nurses and other clinicians into a de-identified, temporally ordered, patient-feature matrix using standardized medical terminologies. We demonstrate how to use the ...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید